- Home
- MMM vs BMY Comparison
MMM vs BMY Comparison
Compare MMM & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMM
- BMY
- Stock Information
- Founded
- MMM 1902
- BMY 1887
- Country
- MMM United States
- BMY United States
- Employees
- MMM N/A
- BMY N/A
- Industry
- MMM Medical/Dental Instruments
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- MMM Health Care
- BMY Health Care
- Exchange
- MMM Nasdaq
- BMY Nasdaq
- Market Cap
- MMM 81.8B
- BMY 94.0B
- IPO Year
- MMM N/A
- BMY N/A
- Fundamental
- Price
- MMM $155.53
- BMY $44.57
- Analyst Decision
- MMM Buy
- BMY Hold
- Analyst Count
- MMM 10
- BMY 15
- Target Price
- MMM $156.00
- BMY $57.64
- AVG Volume (30 Days)
- MMM 2.7M
- BMY 18.1M
- Earning Date
- MMM 10-21-2025
- BMY 10-30-2025
- Dividend Yield
- MMM 1.88%
- BMY 5.55%
- EPS Growth
- MMM 324.65
- BMY N/A
- EPS
- MMM 7.20
- BMY 2.49
- Revenue
- MMM $24,602,000,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- MMM N/A
- BMY N/A
- Revenue Next Year
- MMM $2.89
- BMY N/A
- P/E Ratio
- MMM $21.56
- BMY $17.96
- Revenue Growth
- MMM 0.24
- BMY 2.57
- 52 Week Low
- MMM $121.98
- BMY $42.96
- 52 Week High
- MMM $164.15
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- MMM 50.23
- BMY 43.00
- Support Level
- MMM $154.63
- BMY $44.66
- Resistance Level
- MMM $160.39
- BMY $48.58
- Average True Range (ATR)
- MMM 2.63
- BMY 1.19
- MACD
- MMM 0.06
- BMY 0.05
- Stochastic Oscillator
- MMM 41.07
- BMY 25.88
About MMM 3M Company
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.